TransMedics Group, Inc. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/72c1f183-fd7c-4809-80d5-de99d580dd38/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $190.3M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-150357 |
| FY 2024 | $35.5M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-150357 |
| FY 2023 | $-25.0M | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-150357 |
| FY 2022 | $-36.2M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-017909 |
| FY 2021 | $-44.2M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-018257 |
| FY 2020 | $-28.7M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012527 |
| FY 2019 | $-33.5M | 2018-12-30 – 2019-12-28 | evidence 0001564590-20-011409 |
| FY 2018 | $-23.8M | 2017-12-31 – 2018-12-29 | evidence 0001564590-20-011409 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TransMedics Group, Inc. — all facts · Revenue · Operating Income